Schedule 13G ownership disclosure
BeiGene, Ltd.
Security class unavailable · CUSIP: G1146Y101
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 89,894,623
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-21-000054
- Form type
- SC 13G
- Filer
- BeOne Medicines Ltd.
- CIK
- CIK 1651308
- Filed
- Feb 16, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership